Good solid progress on all fronts. The obviou
Post# of 969
The obvious negative is the overall expense involved with expanding the product line - it far exceed actual current sales.
Shareholders & traders are still in a "show me the money" mindset, as seen by the meager +/- 5% share gain we have seen today.
If Europe/England expansion is as lucrative as the MCOA marketing effort is telling us, look for the lid to be blown off the pricing resistance we are seeing. This is what we are currently waiting on, and it seems to look more and more promising. Until then, its a great buying opportunity, especially with management pursuing the recreational MJ side of things once again..